hydroxychloroquine + vitamin D

Hydroxychloroquine + vitamin D is a non-branded combination of two agents, each with distinct mechanisms and indications. Hydroxychloroquine is a small molecule antimalarial and immunomodulatory drug used primarily for malaria prophylaxis and treatment, as well as autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. It acts mainly by antagonizing toll-like receptor 7 (TLR7) and toll-like receptor 9 (TLR9), modulating immune responses[6]. Vitamin D refers to a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, magnesium, phosphate, and multiple other biological effects; it is essential for bone health, immune modulation, and various metabolic processes. The combination has been studied in the context of certain kidney diseases such as IgA nephropathy (IgAN), where preclinical data suggest that combined therapy may reduce renal injury more effectively than either agent alone[5]. There are also reports that hydroxychloroquine can affect vitamin D metabolism by inhibiting the conversion to its active form in some disease states[1][3][4].